ÖÖÖzgür Özkalaycı

Özgür Özkalaycı

*This is an algorithmically generated author record based on publicly available information.

Özgür Özkalaycı has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The interplay of anxiety and self-esteem in quality of life among patients with a stoma

    by Feride Uysal, Elif Küçük, Özgür Özkalaycı, Mehmet Karahan, Kübra Tetik Albayrak, Yüksel Güleryüzlü, Fırat Çağlar Sezmiş, Merih Altintaş

  • Open Access

    Vitamin D deficiency, depression severity, and suicide risk: evidence from patients with major depressive disorder

    by Eli̇f Küçük, Feri̇dE Uysal, Seda Şenkardeş Kandemi̇r, Özgür Özkalayci, Canay Pamukçu, Ni̇hAl Taşteki̇n, Meri̇h Altintaş

    Background/aim: Major depressive disorder (MDD) is a common psychiatric condition characterized by depressive symptoms and suicide-related clinical features. Vitamin D status has been investigated as a potential clinical correlate of depression and suicidal ideation, but the direction and specificity of these associations remain uncertain. This cross-sectional study aimed to examine the associations among serum 25-hydroxyvitamin D [25(OH)D] levels, depressive symptom severity, suicidal ideation, and suicide-related cognitive–affective dimensions in adults diagnosed with MDD. Materials and methods: This cross-sectional study included 97 adults aged 18–65 years who were diagnosed with MDD according to DSM-5 criteria. Depressive symptom severity and suicide-related outcomes were assessed using the Hamilton Depression Rating Scale (HDRS), Suicidal Ideation Scale (SIS), and Suicide Probability Scale (SPS). Vitamin D status was classified as deficient (<20 ng/ mL), insufficient (20–29 ng/mL), or sufficient (≥30 ng/mL). Associations were examined using multivariable generalized linear models adjusted for available sociodemographic and clinical covariates. Results: Vitamin D deficiency was observed in 61.9% of participants and the mean serum 25(OH)D level was 18.4 ± 11.9 ng/mL. Lower serum 25(OH)D levels were significantly associated with higher HDRS, SIS, and SPS total/subscale scores. In adjusted models, higher serum 25(OH)D levels remained inversely associated with HDRS scores, SIS scores, and total SPS scores. Parental status was also associated with lower SIS scores, while a history of suicide attempts was associated with higher SPS–Suicidal Ideation scores. Conclusion: Lower serum 25(OH)D levels were associated with greater depressive symptom severity and higher suicide-related scale scores in adults with MDD, particularly across cognitive–affective domains relevant to suicide probability. However, given the study’s cross-sectional single-center design, absence of a healthy control group, modest sample size, and adjustment limited to available covariates, these findings should be interpreted as associations rather than evidence of causality, directionality, or established biomarker utility.

  • Open Access

    Firar Suçu İşlemiş Kişilerde Askerliğe Elverişlilik ve Ceza Sorumluluğu

    by Talha Ağaç, Özgür Özkalaycı

    Amaç:Bu çalışmada, firar suçu işlemiş bireylerde askerliğe elverişlilik ve ceza sorumluluğu ile sosyodemografik, klinik ve kriminal özellikler arasındaki ilişkinin incelenmesi amaçlanmıştır.Yöntem:Veriler hastane kayıtlarından elde edilerek retrospektif olarak tasarlanan çalışmaya, 2016–2025 yılları arasında askeri sağlık kuruluna yönlendirilen firar suçu sanığı dahil edilmiştir.Bulgular:82 sanık çalışmaya dahil edilmiştir. Katılımcıların önemli bir kısmında madde kullanım öyküsü (%77,0) ve cezaevi geçmişi (%74,4) bulunmasına rağmen, bu değişkenler ile askerliğe elverişlilik arasında anlamlı ilişki saptanmamıştır (p>0,05). Askerliğe elverişsiz olarak değerlendirilen bireylerin tamamında psikiyatrik tanı bulunmuş olup, gruplar arası en önemli tanısal fark Madde Kullanım Bozukluğu’nda saptanmıştır (p0,05).Sonuç:Firar suçu işlemiş bireylerde askerliğe elverişlilik kararının büyük ölçüde psikiyatrik tanılarla ilişkili olduğu, buna karşın ceza sorumluluğundan bağımsız değerlendirilmesi gerektiği anlaşılmaktadır. Bu bulgular, ceza sorumluluğu değerlendirmesinin her olguda ek klinik katkı sağlamayabileceğini ve bazı durumlarda süreci uzatabileceğini düşündürmektedir.

  • Open Access

    Antipsychotic dose is not associated with cognitive function in patients with schizophrenia aged under 40: a cross-sectional observational study with retrospective dose estimation

    by Özgür Özkalaycı, Nihal Taştekin, Elif Küçük, Feride Uysal

    This study aimed to examine the relationship between antipsychotic dosage and cognitive performance in young patients with schizophrenia. A relatively homogeneous sample was selected to reduce clinical heterogeneity and improve sample comparability. In this cross-sectional observational study, psychotic symptoms were assessed using the Positive and Negative Syndrome Scale (PANSS), and cognitive performance was evaluated with the Montreal Cognitive Assessment (MoCA) in clinically stable patients with schizophrenia under the age of 40 who were followed at a Community Mental Health Center. Total antipsychotic dose was calculated using olanzapine equivalents, and 1-year cumulative exposure was estimated using the mg×day formula. Both frequentist and Bayesian analytical approaches were applied. No significant correlations were found between either daily or cumulative antipsychotic doses and MoCA scores (r = 0.067; p = 0.675; BF₁₀ = 0.260; and r = 0.028; p = 0.864; BF₁₀ = 0.554, respectively). Longer illness duration and higher scores on all PANSS subscales were associated with lower MoCA scores, whereas longer education and older age at diagnosis were positively correlated with cognitive performance. Although prior research has suggested dose-related cognitive impairment, our findings did not provide evidence supporting this association in young, well-characterised patients within the constraints of a cross-sectional observational design. These results indicate that effective therapeutic dosing can be pursued with appropriate clinical monitoring, while acknowledging that potential cognitive effects should still be taken into consideration. The online version contains supplementary material available at 10.1186/s12888-026-08086-x. The online version contains supplementary material available at 10.1186/s12888-026-08086-x.

  • Open Access

    Immunological predictors in first-episode psychosis: findings from one-year prospective follow-up study

    by Talat Sarikavak, Özgür Özkalaycı, Damla İşman Haznedaroğlu, Aytül Zerrin Si̇n, Emine Nihal Mete, Hayriye Elbi̇

    Objective: Emerging evidence suggests that immune dysregulation may play a key role in the pathophysiology of psychosis. However, longitudinal studies integrating both innate and adaptive immune components in the same sample remain scarce. This study aimed to examine a broad spectrum of immunological parameters in first-episode psychosis (FEP) patients, both at onset and after treatment, in comparison to healthy controls. Methods: Thirty-two minimally treated FEP patients (no lifetime psychotropic exposure >1 month) and 26 healthy controls were assessed at baseline. 20 patients completed a follow-up approximately one year later. Immunological markers – including complete blood count (leukocyte, neutrophil, lymphocyte, monocyte), C-reactive protein (CRP), SAA, complement components (C3, C4), and immunoglobulins (IgG, IgA, IgM, IgE) – were measured at both time points. First-episode psychosis was confirmed using SCID (DSM-IV). Symptom severity was evaluated using PANSS and BPRS. ROC and logistic regression analyses were performed to assess predictive value. Results: Neutrophil, monocyte, C3, C4 levels and neutrophil-to-lymphocyte ratio (NLR) were significantly elevated in patients at both time points, with no change over time. CRP was elevated at T1 but normalised at follow-up. In contrast, immunoglobulin levels showed temporal and dimensional associations with symptom severity. NLR was correlated with negative symptoms during the acute phase, while IgG was associated with positive symptoms during remission. Elevated NLR and C4 predicted patient status in logistic regression analysis. Conclusion: This longitudinal study provides a system-level immunological profile across illness phases in FEP. The findings underscore distinct and dynamic contributions of innate and adaptive immunity to the onset and progression of psychosis.

  • Can simple biomarkers of inflammation guide the diagnosis of psychiatric disorders?

    by Ozgur Ozkalayci, Nihal Tastekin

    ObjectiveIn this study, we wanted to investigate the usability of routine blood samples taken at the beginning of hospitalisation in inpatients to predict the presence of psychotic symptoms in patients.MethodsWe divided the hospitalised patients into two groups those with and without psychotic symptoms according to their ICD-10 diagnosis codes. Then, we compared the complete blood count, c-reactive protein (CRP), and fasting glucose levels, which can be used as simple markers of inflammation.ResultsIn this retrospective study, which included 349 patients, we found that blood leukocytes, neutrophils, CRP, and fasting glucose levels were higher in patients with psychotic symptoms than in patients without psychotic symptoms (p = 0.015; p = 0.013; p = 0.002; and p = 0.001, respectively). According to regression analysis, patients with high glucose levels were 4.9 times more likely to have psychotic symptoms than those with low glucose levels. In addition, according to the ROC analysis results; when we used 87 mg/dl as the cut-off value for fasting glucose, it was observed that it predicted psychotic symptoms with approximately 69% sensitivity and 71% specificity.ConclusionAlthough our results still have some limitations, they are promising for the future use of simple biomarkers of inflammation for the differential diagnosis of psychiatric disorders. Inflammatory parameter levels are higher in patients with psychotic symptomsHigh glucose level is assosiated with a higher likelihood of psychotic symptomsBlood fasting glucose levels can be used to predict psychotic symptomsThe difference between groups disappears in repeated hospitalisations.


  • 04 - INVESTIGATION OF IMMUNOLOGICAL PARAMETERS IN THE FIRST EPISODE PSYCHOSIS PATIENTS

    by Talat Sarikavak, Özgür Özkalayci

    Introduction: Schizophrenia and disorders in this spectrum are psychiatric disorders that start at a young age. Current approaches about etiology |